Making and Treating Trans Problems: The Ontological Politics of Clinical Practices
MetadataShow full item record
ABSTRACTAesthetic Plastic Surgeryproduces This essay investigates a divergence between medical and autobiographical accounts of transexuality. By analyzing a letter to the editor in the journal Aesthetic Plastic Surgery that defends trans patients as a “special case” (Selvaggi and Giordano, 2014), I examine how medicine produces trans patients as a separate category of patients. The differential treatment paths of trans and nontrans people who pursue “gender-enhancing” medical interventions demonstrate a double standard that undermines claims to act in the best interest of the patient. Using the evidence of trans men’s accounts of themselves as well as research into the experiences of trans people from across the United Kingdom, Australia, and North America, I critique the medical management of transexuality and call on clinicians to rethink the treatment practices of trans medicine.
Showing items related by title, author, creator and subject.
Prevalence and outcomes of trans-radial access for percutaneous coronary intervention in contemporary practiseAsrar ul Haq, M.; Tsay, I.; Dinh, D.; Brennan, A.; Clark, D.; Cox, N.; Harper, R.; Nadurata, V.; Andrianopoulos, N.; Reid, Christopher; Duffy, S.; Lefkovits, J.; van Gaal, W. (2016)Background: Trans-radial access for percutaneous coronary intervention (PCI) has been associated with lower vascular complication rates and improved outcomes. We assessed the current uptake of trans-radial PCI in Victoria, ...
Regan, S.; Stanger, J.; Yovich, J.; Almahbobi, Ghanim (2012)Introduction: Growth hormone (GH) exerts multiple functions including its effect on the reproductive system1. We have recently reported that GH supplementation improves implantation and pregnancy rates for poor-prognosis ...
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypesSmitheman, K.N.; Severson, T.M.; Rajapurkar, S.R.; McCabe, M.T.; Karpinich, N.; Foley, J.; Pappalardi, M.B.; Hughes, A.; Halsey, W.; Thomas, E.; Traini, C.; Federowicz, K.E.; Laraio, J.; Mobegi, Fredrick ; Ferron-Brady, G.; Prinjha, R.K.; Carpenter, C.L.; Kruger, R.G.; Wessels, L.; Mohammad, H.P. (2019)Lysine specific demethylase 1 (LSD1) is a histone modifying enzyme that suppresses gene expression through demethylation of lysine 4 on histone H3. The anti-tumor activity of GSK2879552 and GSK-LSD1, potent, selective ...